These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 25548132)
1. Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer. Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Taniguchi D; Nagayasu T Eur J Cardiothorac Surg; 2015 Apr; 47(4):e140-5. PubMed ID: 25548132 [TBL] [Abstract][Full Text] [Related]
2. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections. Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918 [TBL] [Abstract][Full Text] [Related]
3. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification]. Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272 [TBL] [Abstract][Full Text] [Related]
4. Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients. Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Kamohara R; Hatachi G; Doi R; Obata T; Nagayasu T Surg Today; 2017 Jul; 47(7):836-843. PubMed ID: 27853867 [TBL] [Abstract][Full Text] [Related]
5. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Birim O; Kappetein AP; Bogers AJ Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485 [TBL] [Abstract][Full Text] [Related]
6. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer. Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer. Zhang H; Xia H; Zhang L; Zhang B; Yue D; Wang C Am J Surg; 2015 Sep; 210(3):526-35. PubMed ID: 26105800 [TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer. Osugi J; Muto S; Matsumura Y; Higuchi M; Suzuki H; Gotoh M J Cancer Res Ther; 2016; 12(2):945-51. PubMed ID: 27461679 [TBL] [Abstract][Full Text] [Related]
9. Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection†. Guerrera F; Errico L; Evangelista A; Filosso PL; Ruffini E; Lisi E; Bora G; Asteggiano E; Olivetti S; Lausi P; Ardissone F; Oliaro A Eur J Cardiothorac Surg; 2015 Jun; 47(6):1037-43. PubMed ID: 25391390 [TBL] [Abstract][Full Text] [Related]
10. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone. Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805 [TBL] [Abstract][Full Text] [Related]
11. Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases. Bergman P; Brodin D; Lewensohn R; de Petris L Acta Oncol; 2013 Aug; 52(6):1189-94. PubMed ID: 23215828 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection. Wang CY; Lin YS; Tzao C; Lee HC; Huang MH; Hsu WH; Hsu HS Eur J Cardiothorac Surg; 2007 Dec; 32(6):877-81. PubMed ID: 17920921 [TBL] [Abstract][Full Text] [Related]
13. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer]. Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391 [TBL] [Abstract][Full Text] [Related]
14. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection. Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495 [TBL] [Abstract][Full Text] [Related]
15. Significance of the Glasgow Prognostic Score as a prognostic indicator for lung cancer surgery. Kawashima M; Murakawa T; Shinozaki T; Ichinose J; Hino H; Konoeda C; Tsuchiya T; Murayama T; Nagayama K; Nitadori J; Anraku M; Nakajima J Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):637-43. PubMed ID: 26269495 [TBL] [Abstract][Full Text] [Related]
16. Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer. Brunelli A; Pompili C; Berardi R; Mazzanti P; Onofri A; Salati M; Cascinu S; Sabbatini A Ann Thorac Surg; 2012 Jun; 93(6):1796-800. PubMed ID: 22551844 [TBL] [Abstract][Full Text] [Related]
17. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome. Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pre- and postoperative glasgow prognostic score for patients with non-small cell lung cancer. Tomita M; Ayabe T; Chosa E; Nakamura K Anticancer Res; 2014 Jun; 34(6):3137-40. PubMed ID: 24922684 [TBL] [Abstract][Full Text] [Related]
19. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer. Cannon NA; Meyer J; Iyengar P; Ahn C; Westover KD; Choy H; Timmerman R J Thorac Oncol; 2015 Feb; 10(2):280-5. PubMed ID: 25299234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]